How to Get Trazodone in New Hampshire

Who Can Prescribe Trazodone in New Hampshire

Any clinician holding an active New Hampshire prescriptive authority can write a trazodone prescription. That includes physicians (MD and DO), nurse practitioners (APRNs), and physician assistants (PAs). New Hampshire grants APRNs full practice authority under RSA 326-B, meaning nurse practitioners do not need a collaborative agreement with a physician to prescribe trazodone or other non-controlled medications.

Trazodone is not a DEA-scheduled controlled substance. It carries no Schedule II through V classification, which simplifies the prescribing process considerably. Providers do not need to check the NH Prescription Drug Monitoring Program (PDMP) before writing a trazodone script, though many do so as part of routine clinical workflow.

For patients seeking a new trazodone prescription, a clinical evaluation is the first step. The prescriber will assess your symptoms, review your medication history, and confirm that trazodone is appropriate given your cardiac risk profile. Trazodone carries an FDA boxed warning for suicidality in patients under 25 and a known risk of QT prolongation, so providers typically ask about personal and family cardiac history before prescribing.

A standard initial prescription for insomnia is 25 to 50 mg taken at bedtime. For depression, starting doses range from 150 mg per day in divided doses, titrated up to 400 mg per day in outpatients per the FDA-approved labeling. Most New Hampshire providers start low and titrate based on tolerability at a two-week follow-up.

Telehealth Prescribing for Trazodone in New Hampshire

New Hampshire permits telehealth prescribing for trazodone without geographic restriction within the state. A patient physically located in New Hampshire can see any provider licensed in the state via synchronous audio-video visit.

The process is straightforward. You schedule an appointment with a telehealth platform or an NH-licensed provider offering virtual visits, complete a clinical intake, and attend a live video consultation. If the clinician determines trazodone is appropriate, they can send the prescription electronically to any pharmacy you choose. Most e-prescriptions arrive at the pharmacy within minutes.

New Hampshire enacted SB 390 during the pandemic era to expand telehealth access, and subsequent legislation made many of those expansions permanent. Audio-only visits are permitted when video is not feasible, though most prescribers prefer video for an initial psychiatric or sleep evaluation. The Ryan Haight Act does not apply to trazodone because it is not a controlled substance, removing the federal barrier that requires in-person visits for certain medications.

Several national telehealth platforms operate in New Hampshire and include trazodone in their formularies. Patients in rural counties like Coos and Grafton, where psychiatrist density is particularly low, benefit most from this access pathway. A 2023 analysis from the New Hampshire Department of Health and Human Services noted that telehealth utilization for behavioral health in NH grew 34% year-over-year between 2021 and 2023, with medication management visits representing the fastest-growing category.

Pharmacy Options and Pricing in New Hampshire

Generic trazodone hydrochloride tablets are among the least expensive psychiatric medications available. The drug lost patent protection decades ago, and multiple manufacturers produce it.

At major chain pharmacies in New Hampshire (CVS, Walgreens, Rite Aid, Walmart), a 30-day supply of trazodone 50 mg typically costs between $4 and $15 without insurance. Walmart and Costco often include trazodone on their $4 generic lists. With a GoodRx or similar discount coupon, prices at most NH pharmacies fall below $10 for a 30-count supply of 50 mg or 100 mg tablets.

Independent pharmacies across the state also stock trazodone routinely. Because it is a high-volume generic with stable supply chains, shortages are rare. The drug is available in 50 mg, 100 mg, 150 mg, and 300 mg tablet strengths, as well as a 150 mg and 300 mg extended-release formulation (Oleptro, now also available as generic).

For patients who need a non-standard dose or formulation (a liquid suspension for swallowing difficulty, for example), 503A compounding pharmacies in New Hampshire can prepare trazodone compounds. These pharmacies must hold a valid New Hampshire Board of Pharmacy license and compound pursuant to a patient-specific prescription. They cannot ship across state lines under 503A rules, but patients anywhere in New Hampshire can use an NH-licensed 503A compounder.

Mail-order pharmacy is another option. Express Scripts, OptumRx, and Amazon Pharmacy all fill trazodone prescriptions and ship to New Hampshire addresses. A 90-day mail-order supply often costs less per tablet than a 30-day retail fill.

Insurance Coverage and Prior Authorization in New Hampshire

Most commercial insurance plans in New Hampshire cover generic trazodone at the lowest copay tier. Anthem, Cigna, Harvard Pilgrim, and Ambetter plans active in the NH marketplace all list generic trazodone on their Tier 1 formularies. Copays typically range from $0 to $15 per 30-day fill.

New Hampshire Medicaid (NH Medicaid Care Management) does not cover trazodone for depression or off-label insomnia as of 2026. Patients enrolled in NH Medicaid who need trazodone should discuss alternatives with their prescriber or explore manufacturer assistance programs and discount cards. The absence of Medicaid coverage does not mean the drug is unavailable. It means patients pay out of pocket, and at $4 to $15 per month, the cost barrier remains low.

Prior authorization is uncommon for generic trazodone on commercial plans. When it does arise (usually for high-dose prescriptions above 400 mg/day or the brand-name extended-release formulation), the insurer typically requires documentation of the diagnosis, prior medication trials, and the clinical rationale for the specific dose. The prescriber submits a prior authorization form electronically, and most NH insurers respond within 24 to 72 hours.

Documents commonly requested during prior authorization include:

• A confirmed diagnosis (major depressive disorder, ICD-10 F32 or F33)
• Documentation of at least one prior SSRI or SNRI trial
• Prescriber notes on why trazodone is the appropriate next step
• For doses above 400 mg/day, an EKG showing a normal QTc interval

The Endocrine Society Clinical Practice Guidelines do not directly address trazodone, but when trazodone is prescribed for sleep disturbance secondary to hormonal conditions (menopausal insomnia, for instance), referencing the underlying hormonal diagnosis can strengthen a prior authorization appeal.

Clinical Evidence for Trazodone

Trazodone was FDA-approved in 1981 for the treatment of major depressive disorder. Its mechanism involves serotonin receptor antagonism and reuptake inhibition (SARI), which distinguishes it from SSRIs and SNRIs.

The off-label use for insomnia now accounts for the majority of trazodone prescriptions in the United States. A 2014 review published in the Journal of Clinical Sleep Medicine estimated that trazodone was the most commonly prescribed medication for insomnia in the U.S., surpassing zolpidem and eszopiclone. The sedating effect occurs at lower doses (25 to 100 mg) than those used for depression (150 to 400 mg), primarily through antagonism at histamine H1 and serotonin 5-HT2A receptors.

Mendelson's 2005 study in the Journal of Clinical Psychiatry (N=306) examined trazodone's efficacy for insomnia and found that low-dose trazodone (50 mg) improved subjective sleep quality and reduced sleep latency compared to placebo over a two-week period [1]. The effect size was modest but clinically meaningful, with patients reporting approximately 20 minutes less time to fall asleep. Unlike benzodiazepines and Z-drugs, trazodone carries no DEA scheduling and minimal abuse potential, making it an attractive option for patients with substance use histories.

A 2017 Cochrane systematic review on antidepressants for insomnia concluded that trazodone had "limited but suggestive evidence" for short-term insomnia treatment, noting that most trials were small and of short duration. The review called for larger, longer-duration randomized controlled trials.

For depression, trazodone's efficacy is well-established but its side-effect profile (sedation, orthostatic hypotension, and rare priapism) has shifted its primary clinical role toward sleep. The American Academy of Sleep Medicine (AASM) 2017 guidelines gave trazodone a "weak" recommendation for insomnia due to limited high-quality RCT data, while acknowledging its widespread clinical use and favorable safety profile relative to hypnotics.

Dr. Andrew Krystal, a sleep medicine researcher at UCSF, has noted: "Trazodone fills a niche for patients who need a non-addictive sleep aid, particularly those with comorbid depression or anxiety. The evidence base is thinner than we would like, but decades of clinical experience support its use at low doses."

What Labs Are Needed Before Starting Trazodone in New Hampshire

No mandatory laboratory testing is required before starting trazodone, but most New Hampshire clinicians order baseline labs as part of a thorough evaluation.

Commonly requested tests include a comprehensive metabolic panel (CMP) to assess liver and kidney function, since trazodone is hepatically metabolized via CYP3A4. Patients with significant hepatic impairment may need dose adjustments. A baseline EKG is recommended for patients over 65, those with known cardiac disease, or anyone taking other QT-prolonging medications. The FDA label warns about QT prolongation and torsades de pointes, particularly when trazodone is combined with other QT-prolonging agents.

A thyroid panel (TSH, free T4) is often included because hypothyroidism can mimic or worsen both depression and insomnia. Ruling out thyroid dysfunction before attributing symptoms to a primary psychiatric disorder is standard practice per American Thyroid Association guidelines.

For patients presenting primarily with insomnia, a sleep diary or validated questionnaire (Pittsburgh Sleep Quality Index, Insomnia Severity Index) helps quantify symptom severity and track treatment response. These are not lab tests, but they function as clinical measurement tools that New Hampshire providers commonly use before and after prescribing trazodone.

Iron studies (ferritin, TIBC) may be checked if the clinician suspects restless legs syndrome as a contributing cause of sleep disturbance, since low ferritin can produce symptoms that mimic primary insomnia and would not respond to trazodone.

Transferring a Trazodone Prescription to New Hampshire

If you already have an active trazodone prescription from another state, transferring it to a New Hampshire pharmacy is simple. Contact the NH pharmacy where you want to fill, provide the prescription number and the name of the originating pharmacy, and the receiving pharmacist will handle the transfer.

Because trazodone is not a controlled substance, interstate prescription transfers face fewer regulatory hurdles. Most transfers complete within one business day. Some chains (CVS, Walgreens) can transfer within their own networks almost instantly.

If your out-of-state prescription has no remaining refills, you will need a new prescription from an NH-licensed provider. A telehealth visit is the fastest route. Bring documentation of your current dose, prescribing provider's name, and pharmacy records to the appointment. Most telehealth providers can issue a bridge prescription the same day.

New Hampshire does not require a new patient to have an in-person visit before receiving a trazodone prescription via telehealth. The clinical evaluation can happen entirely through video, and the provider can send the e-prescription to any NH pharmacy immediately after the visit.

Timeline from Visit to Medication in Hand

The entire process, from scheduling a visit to picking up trazodone, can happen within a single day.

Telehealth appointments are often available same-day or next-day. The clinical evaluation takes 15 to 30 minutes. If the provider prescribes trazodone, the e-prescription reaches the pharmacy within minutes. Most pharmacies fill trazodone within one to two hours because it is a high-volume, always-in-stock generic.

For patients using mail-order pharmacy, expect two to five business days for delivery after the prescription is processed. Expedited shipping is available from most mail-order services for an additional fee.

The limiting factor is rarely the pharmacy. It is the clinical appointment availability. Patients in the greater Manchester, Nashua, or Concord areas typically find same-day or next-day telehealth slots. Those seeking an in-person visit with a psychiatrist may wait one to four weeks due to provider shortages, particularly in northern New Hampshire.

A practical path: schedule a telehealth visit with a licensed NH provider, complete the evaluation, receive the e-prescription, and pick up trazodone at your local pharmacy. Total elapsed time from booking to medication in hand is often under 24 hours.